Back to Search
Start Over
Long-term efficacy and safety of itolizumab in patients with moderate-to-severe chronic plaque psoriasis: A double-blind, randomized-withdrawal, placebo-controlled study.
- Source :
-
Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2015 Aug; Vol. 73 (2), pp. 331-3.e1. - Publication Year :
- 2015
- Subjects :
- Adult
Antibodies, Monoclonal, Humanized adverse effects
Dose-Response Relationship, Drug
Double-Blind Method
Drug Administration Schedule
Female
Follow-Up Studies
Humans
Infusions, Intravenous
Male
Maximum Tolerated Dose
Middle Aged
Risk Assessment
Severity of Illness Index
Time
Treatment Outcome
Withholding Treatment
Antibodies, Monoclonal, Humanized administration & dosage
Psoriasis diagnosis
Psoriasis drug therapy
Quality of Life
Subjects
Details
- Language :
- English
- ISSN :
- 1097-6787
- Volume :
- 73
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Journal of the American Academy of Dermatology
- Publication Type :
- Report
- Accession number :
- 26183983
- Full Text :
- https://doi.org/10.1016/j.jaad.2015.03.040